본문 바로가기
KERD
논문KCI 등재

7,8-Dihydroxyflavone, a Tropomyosin-Kinase Related Receptor B Agonist, Produces Fast-Onset Antidepressant-Like Effects in Rats Exposed to Chronic Mild Stress

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류정신과학

초록

ObjectiveaaBrain-derived neurotrophic factor (BDNF) and its specific receptor, tropomyosin-related kinase (TrkB), play important roles in treating depression. In this experiment, we examined whether 7,8-dihydroxyflavone, a novel potent TrkB agonist, could reverse the behavioral and biochemical abnormalities induced by the chronic mild stress (CMS) paradigm in rats. MethodsaaSD rats were exposed to a battery of stressors for 56 days. 7,8-dihydroxyflavone (5 and 20 mg/kg) were administered intraperitoneally during the last 28 days of the CMS paradigm. Rats were tested in sucrose consumption test (SCT), forced-swimming test (FST) and elevated T-maze (ETM). Serum corticosterone levels and hippocampal BDNF levels of the rats were measured. ResultsaaFour-week CMS on the rats induced their depression-like behavior in SCT. The CMS-reduced sucrose consumption was reversed starting from 7 days after the 7,8-dihydroxyflavone (20 mg/kg) treatment and remained across the subsequent treatment regime. 7,8-dihydroxyflavone, when given at 5 mg/kg for 3 weeks, reduced the immobility time in the FST in the CMS-subjected rats. Additionally, the 4-week treatment with 7,8-dihydroxyflavone (20 mg/kg) attenuated the CMS-induced increase in anxiety-like behavior in the ETM. For the CMS-subjected rats, 7,8-dihydroxyflavone treatment dose-dependently reduced their serum corticosterone levels but increased their hippocampal BDNF levels only at 5 mg/kg. Conclusion 7,8-dihydroxyflavone was beneficial for both depression and anxiety-like behaviors, and may exert fast-onset antidepressant effects. This provides a new insight into the pharmacological management of depression.

Abstract

Objective Brain-derived neurotrophic factor (BDNF) and its specific receptor, tropomyosin-related kinase (TrkB), play important roles in treating depression. In this experiment, we examined whether 7,8-dihydroxyflavone, a novel potent TrkB agonist, could reverse the behavioral and biochemical abnormalities induced by the chronic mild stress (CMS) paradigm in rats. Methods SD rats were exposed to a battery of stressors for 56 days. 7,8-dihydroxyflavone (5 and 20 mg/kg) were administered intraperitoneally during the last 28 days of the CMS paradigm. Rats were tested in sucrose consumption test (SCT), forced-swimming test (FST) and elevated T-maze (ETM). Serum corticosterone levels and hippocampal BDNF levels of the rats were measured. Results Four-week CMS on the rats induced their depression-like behavior in SCT. The CMS-reduced sucrose consumption was reversed starting from 7 days after the 7,8-dihydroxyflavone (20 mg/kg) treatment and remained across the subsequent treatment regime. 7,8-dihydroxyflavone, when given at 5 mg/kg for 3 weeks, reduced the immobility time in the FST in the CMS-subjected rats. Additionally, the 4-week treatment with 7,8-dihydroxyflavone (20 mg/kg) attenuated the CMS-induced increase in anxiety-like behavior in the ETM. For the CMS-subjected rats, 7,8-dihydroxyflavone treatment dose-dependently reduced their serum corticosterone levels but increased their hippocampal BDNF levels only at 5 mg/kg. Conclusiona 7,8-dihydroxyflavone was beneficial for both depression and anxiety-like behaviors, and may exert fast-onset antidepressant effects. This provides a new insight into the pharmacological management of depression.

참고문헌 (62)

  1. Johnson JE, "Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells", J Neurosci, 6, pp.3031~3038 (1986)
  2. Castren E, "Neuronal network plasticity and recovery from depression", JAMA Psychiatry, 70, pp.983~989 (2013)
  3. Molendijk ML, "Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment", Mol Psychiatry, 16, pp.1088~1095 (2011)
  4. Taliaz D, "Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis", Mol Psychiatry, 15, pp.80~92 (2010)
  5. Angelucci F, "BDNF in schizophrenia, depression and corresponding animal models", Mol Psychiatry, 10, pp.345~352 (2005)
  6. Kerman IA, "New insights into BDNF signaling : relevance to major depression and antidepressant action", Am J Psychiatry, 169, pp.1137~1140 (2012)
  7. Gentry JJ, "The p75 neurotrophin receptor : multiple interactors and numerous functions", Prog Brain Res, 146, pp.25~39 (2004)
  8. Gan WB, "TrkB works at postsynaptic sites", Neuron, 24, pp.491~492 (1999)
  9. Black IB, "Trophic regulation of synaptic plasticity", J Neurobiol, 41, pp.108~118 (1999)
  10. Lee J, "Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice", J Neurochem, 82, pp.1367~1375 (2002)
  11. Ernfors P, "The coupling of a trkB tyrosine residue to LTP", Trends Neurosci, 26, pp.171~173 (2003)
  12. Poduslo JF, "Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF", Brain Res Mol Brain Res, 36, pp.280~286 (1996)
  13. Massa SM, "Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents", J Clin Invest, 120, pp.1774~1785 (2010)
  14. Jang SW, "A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone", Proc Natl Acad Sci U S A, 107, pp.2687~2692 (2010)
  15. Devi L, "7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer’s disease", Neuropsychopharmacology, 37, pp.434~444 (2012)
  16. Zeng Y, "Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging", J Alzheimers Dis, 31, pp.765~778 (2012)
  17. Zhang Z, "7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease", Neuropsychopharmacology, 39, pp.638~650 (2014)
  18. Liu X, "A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect", J Med Chem, 53, pp.8274~8286 (2010)
  19. Blugeot A, "Vulnerability to depression : from brain neuroplasticity to identification of biomarkers", J Neurosci, 31, pp.12889~12899 (2011)
  20. Bielajew C, "The effects of chronic mild stress on male Sprague-Dawley and Long Evans rats: I. Biochemical and physiological analyses", Behav Brain Res, 136, pp.583~592 (2002)
  21. Liu D, "Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats", Behav Brain Res, 264, pp.9~16 (2014)
  22. Ballenger JC, "Clinical guidelines for establishing remission in patients with depression and anxiety", J Clin Psychiatry, 60(Suppl 22), pp.29~34 (1999)
  23. Hashimoto K, "Critical role of brain-derived neurotrophic factor in mood disorders", Brain Res Brain Res Rev, 45, pp.104~114 (2004)
  24. Middeldorp CM, "Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes?", Genes Brain Behav, 9, pp.808~816 (2010)
  25. Baker-Andresen D, "Activation of BDNF signaling prevents the return of fear in female mice", Learn Mem, 20, pp.237~240 (2013)
  26. Andero R, "Fear extinction and BDNF : translating animal models of PTSD to the clinic", Genes Brain Behav, 11, pp.503~512 (2012)
  27. Castello NA, "7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss", PLoS One, 9, pp.e91453~ (2014)
  28. Viana MB, "The elevated T-maze : a new animal model of anxiety and memory", Pharmacol Biochem Behav, 49, pp.549~554 (1994)
  29. Zangrossi H Jr, "Behavioral validation of the elevated T-maze, a new animal model of anxiety", Brain Res Bull, 44, pp.1~5 (1997)
  30. Willner P, "Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation", Psychopharmacology, 134, pp.319~329 (1997)
  31. Willner P, "Chronic mild stress(CMS)revisited : consistency and behavioural-neurobiological concordance in the effects of CMS", Neuropsychobiology, 52, pp.90~110 (2005)
  32. Grippo AJ, "Behavioral and cardiovascular changes in the chronic mild stress model of depression", Physiol Behav, 78, pp.703~710 (2003)
  33. Becker C, "Repeated social defeat-induced depression-like behavioral and biological alterations in rats : involvement of cholecystokinin", Mol Psychiatry, 13, pp.1079~1092 (2008)
  34. Nibuya M, "Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus", J Neurosci, 16, pp.2365~2372 (1996)
  35. Smith MA, "Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus", J Neurosci, 15, pp.1768~1777 (1995)
  36. Nibuya M, "Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments", J Neurosci, 15, pp.7539~7547 (1995)
  37. Russo-Neustadt A, "Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression", Neuropsychopharmacology, 21, pp.679~682 (1999)
  38. Szapacs ME, "Exploring the relationship between serotonin and brain-derived neurotrophic factor : analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression", J Neurosci Methods, 140, pp.81~92 (2004)
  39. Zhang JC, "Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression", Psychopharmacology, 232, pp.4325~4335 (2015)
  40. Wyneken U, "Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses", Neuropsychopharmacology, 31, pp.2415~2423 (2006)
  41. Zhang JC, "Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation", Int J Neuropsychopharmacol, 18 (2014)
  42. Li N, "mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists", Science, 329, pp.959~964 (2010)
  43. Li N, "Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure", Biol Psychiatry, 69, pp.754~761 (2011)
  44. Yang SN, "Effects of escitalopram on a rat model of persistent stress-altered hedonic activities : towards a new understanding of stress and depression", Chin J Physiol, 58, pp.404~411 (2015)
  45. Matuszewich L, "The delayed effects of chronic unpredictable stress on anxiety measures", Physiol Behav, 90, pp.674~681 (2007)
  46. Bondi CO, "Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment", Neuropsychopharmacology, 33, pp.320~331 (2008)
  47. Kompagne H, "Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats", Behav Brain Res, 193, pp.311~314 (2008)
  48. Jindal A, "Etazolate rescues behavioral deficits in chronic unpredictable mild stress model : modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level", Neurochem Int, 63, pp.465~475 (2013)
  49. Xu Y, "Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB", Brain Res, 1122, pp.56~64 (2006)
  50. Zheng H, "Beneficial effects of exercise and its molecular mechanisms on depression in rats", Behav Brain Res, 168, pp.47~55 (2006)
  51. Schaaf MJ, "Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation", Stress, 3, pp.201~208 (2000)
  52. Yau SY, "Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats", PLoS One, 6, pp.e24263~ (2011)
  53. Adachi M, "Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy", Biol Psychiatry, 63, pp.642~649 (2008)
  54. Duman CH, "A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment", Biol Psychiatry, 61, pp.661~670 (2007)
  55. Santarelli L, "Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants", Science, 301, pp.805~809 (2003)
  56. Gould E, "Neurogenesis in adult mammals : some progress and problems", J Neurosci, 22, pp.619~623 (2002)
  57. Mitsukawa K, "Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels : implications for stress-related psychiatric disorders", Neuropsychopharmacology, 31, pp.1112~1122 (2006)
  58. Wu CH, "Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K", Akt signaling, 2014, pp.9, e113397~
  59. Lonze BE, "Function and regulation of CREB family transcription factors in the nervous system", Neuron, 35, pp.605~623 (2002)
  60. Sommerfeld MT, "Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB", J Biol Chem, 275, pp.8982~8990 (2000)
  61. Kong AN, "Signal transduction events elicited by natural products : role of MAPK and caspase pathways in homeostatic response and induction of apoptosis", Arch Pharm Res, 23, pp.1~16 (2000)
  62. Granado-Serrano AB, "Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase", Akt and ERK pathways in a human hepatoma cell line (HepG2), 2006, pp.136, 2715~2721

관련 논문AI추천

Acute Stress and Chronic Stress Change Brain-Derived Neurotrophic Factor (BDNF) and Tyrosine Kinase- Coupled Receptor (TrkB) Expression in Both Young and Aged Rat HippocampusBang-ping Yuan, Fang Pan, Shou-Sen Shi, Shu-hong Shao, Zun-Ling Li연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제5호Reversion of BDNF, Akt and CREB in Hippocampus of Chronic Unpredictable Stress Induced Rats: Effects of Phytochemical, Bacopa MonnieriAmal Chandra Mondal, Goutam Kumar Saha, Somoday Hazra, Sourav Kumar대한신경정신의학회 · PSYCHIATRY INVESTIGATION2017 · 제14권 제1호Danshensu Interventions Mediate Rapid Antidepressant Effects by Activating the Mammalian Target of Rapamycin Signaling and Brain-Derived Neurotrophic Factor ReleaseChih-Chia Huang, Han-Wen Chuang, I-Hua Wei, Jou-Hua Ren, Kuang-Ti Chen, Mang-Hung Tsai, Po-Ting Chen, Tse-Yen Wang, Yen-Yu Kuo대한신경정신의학회 · PSYCHIATRY INVESTIGATION2024 · 제21권 제11호한약처방 JSB가 구금스트레스로 우울증을 유발한 생쥐의 행동과 생체지표에 미치는 영향김가나, 김연경, 신윤민, 이원길, 임형택, 장희진, 최정준, 황은영대한한방신경정신과학회 · 동의신경정신과학회지2021 · 제32권 제1호Synurus deltoides Alleviates Anti-Depressive Like Behavior Dysfunction Induced by Chronic Unpredictable Mild Stress via Stress-Related CRF/TLR PathwayEo Hyun Ji, Go Min Ji, Heo Ho Jin, Joo Seung Gyum, Kim Hyun-Jin, Kim Jong Min, Kim Ju Hui, Kim Tae Yoon, Lee Han Su, Lee Hyo Lim한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 만성구속스트레스 동물모델에 대한 JG02의 항우울 효과김주연, 서영경, 유동근, 이지윤, 정인철, 정진형, 최정준대한한방신경정신과학회 · 동의신경정신과학회지2019 · 제30권 제3호

이 간행물의 다른 논문 (10건)